Acambis PLC
Peterhouse Technology Park
100 Fulbourn Road
Cambridge
CB19PT
United Kingdom
Tel: 44-1223-275300
Fax: 44-1223-416300
Website: http://www.acambis.com/
Email: acambis@acambis.com
70 articles about Acambis PLC
-
Sanofi-Aventis (France) to Buy Vaccine Maker Acambis PLC (JOBS) for $548 Million
7/25/2008
-
Acambis PLC Wins $425M US Smallpox Vaccine Contract
4/23/2008
-
Acambis PLC Extends Sanofi Pasteur Licensing Agreement for ChimeriVax-JE Vaccine
3/20/2008
-
Acambis PLC Initiates Pre-Clinical Testing with Herpes Vaccine from Harvard Medical School
2/25/2008
-
Acambis PLC Welcomes US Department of Defense's Transition to ACAM2000(TM) as Its Only Smallpox Vaccine
2/14/2008
-
Acambis PLC Welcomes US Department of Defense's Transition to ACAM2000(TM) as Its Only Smallpox Vaccine
2/13/2008
-
Positive Phase I and Pre-Clinical Data Suggest Acambis PLC's M2e-Based Universal Influenza Vaccine, ACAM-FLU-A(TM), Could Tackle Influenza Pandemics
1/3/2008
-
Acambis PLC Reports Positive Data from Trials of Universal Influenza A Vaccine
1/3/2008
-
Acambis PLC Delivers ACAM2000(TM) Doses to US Government; Increases 2007 Revenue Expectations
1/3/2008
-
Acambis PLC Concludes C. difficile Vaccine Formulation Work on Schedule and Will Commence Proof-of-Concept trial in 2008
12/18/2007
-
Acambis PLC Updates on Strategy and Reports Important Progress During Six Months Ended 30 June 2007
9/25/2007
-
Acambis PLC Appoints Elizabeth Jones as Chief Financial Officer
9/25/2007
-
Acambis PLC Welcomes Sanofi Pasteur's Dengue Vaccine Progress
9/18/2007
-
FDA Approves Acambis PLC's (Jobs) ACAM2000(TM) Vaccine for Protection Against Smallpox
9/4/2007
-
Bavarian Nordic and Acambis PLC Settle all Legal Disputes on MVA
7/26/2007
-
Acambis PLC's Universal Influenza Vaccine Enters Phase 1 Trial
7/17/2007
-
FDA Advisory Committee Unanimously Votes in Favor of Acambis PLC's Smallpox Vaccine
5/18/2007
-
Acambis PLC Wins Delaware MVA Case
5/18/2007
-
Acambis PLC's Smallpox Vaccine Meets Main Goal Says FDA Staff
5/15/2007
-
Acambis PLC Results for the First Quarter Ended 31 March 2007
5/10/2007